The company introduced technologies like Next-Generation Sequencing and Sanger Sequencing nearly a decade ago.

NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...

Patient ID Now, a coalition of leading healthcare organizations, applauds the reintroduction of H.R.2002, the Patient Matching and Transparency in Certified Health IT (MATCH IT) Act of 2025 by ...

The AHA and Press Ganey today released a new report showing hospital and health system patients reporting improvements in overall care experience and perception of safety alongside gains in key safety ...

Bindman, a professor at the University of California-San Francisco medical school, has spent well over a decade researching ...

About 800 foodborne illness outbreaks occur in the United States every year, sickening more than 15,000 people, with one of the most frequent causes of ...

It's part of a new campaign by the Maryland Patient Safety Center to combat violence against nurses and healthcare staff.

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025Denifanstat received Breakthrough Therapy ...

Live updates and the latest news as U.S. tariffs on steel and aluminum kick in and the Senate turns to a government funding ...

A new suite of dental imaging reports provides comprehensive insights into the Global, European, and United States dental ...

GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This "first ...

Former Buffalo Bills quarterback Doug Flutie credits his time playing in Buffalo and the support of Western New Yorkers for his autism-focused charity really taking off and growing.